Darunavir 600 mg
Developed as a second-generation protease inhibitor, Darunavir 600 mg Tablets are used in boosted antiretroviral regimens to manage HIV-1 infection, particularly in patients requiring protease inhibitor–based therapy under recommended treatment frameworks.
Product Details
Therapeutic Class
Protease Inhibitor (Antiretroviral)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
600 mg administered with a pharmacokinetic booster (such as ritonavir) and in combination with other antiretroviral agents, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
60 tablets
Darunavir 600 mg
Developed as a second-generation protease inhibitor, Darunavir 600 mg Tablets are used in boosted antiretroviral regimens to manage HIV-1 infection, particularly in patients requiring protease inhibitor–based therapy under recommended treatment frameworks.
Product Details
Therapeutic Class
Protease Inhibitor (Antiretroviral)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
600 mg administered with a pharmacokinetic booster (such as ritonavir) and in combination with other antiretroviral agents, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
60 tablets
Darunavir 600 mg
Developed as a second-generation protease inhibitor, Darunavir 600 mg Tablets are used in boosted antiretroviral regimens to manage HIV-1 infection, particularly in patients requiring protease inhibitor–based therapy under recommended treatment frameworks.
Product Details
Therapeutic Class
Protease Inhibitor (Antiretroviral)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
600 mg administered with a pharmacokinetic booster (such as ritonavir) and in combination with other antiretroviral agents, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
60 tablets